Demonstration of a polymorphism in the gene ERCC1 by two DNA sequencing methods

Oncology Reports

Volumn 4, Issue 5, 1997, Pages 905-907

  Yu, Jing Jie ^a   Reed, Edward L ^a   Mu, Chuanjie ^a   Bostick Bruton, Frieda ^a   Reed, Eddie ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

DNA repair; ERCC1; Ovarian cancer

Indexed keywords

ARTICLE; CODON; DNA SEQUENCE; EXON; FEMALE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 0030741285     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.5.905     Document Type: Article

References (18)

1. Maxam AM and Gilbert W: Sequencing end-labeled DNA with base-specific chemical cleavages. Method Enzymol 65: 499-560, 1980.
2. Sanger F: Sequences, sequences, and sequences. Annu Rev Biochem 57: 1-28, 1988.
3. Sanger F and Coulson AR: A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 94: 441-448, 1975.
4. Yin ZB, Severin J, Giddings MC, Huang WA, Westphall MS and Smith LM: Automatic matrix determination in four dye fluorescence-based DNA sequencing. Electrophoresis 17: 1143-1150, 1996.
5. Maniatis T, Fritsch EF and Sambrook J: Molecular Cloning: A Laboratory Manual. 2nd edition. Vol. 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 18.60-18.66, 1989.
6. Van Duin M, Koken MHM, van den Tol J, ten Dijke P, Odijk H, Westerveld A, Bootsma D and Hoeijmakers JHJ: Genomic characterization of the human DNA excision repair gene ERCC-1. Nucleic Acids Res 15: 9195-9213, 1987.
7. Yu JJ, Dabholkar M, Bennett W, Welsh JA, Mu C, Bostick-Bruton F, Vionnet JA and Reed E: Platinum-sensitive and platinum-resistant ovarian cancer tissues show differences in the relationships between p53, ERCC1, and XPA. Int J Oncol 8: 313-317, 1996.
8. Yu JJ, Mu C, Lee KB, Okamoto A, Reed EL, Bostick-Bruton F, Mitchell KC and Reed E: A nucleotide polymorphism in ERCC1 gene in human ovarian cancer cell lines and tumor tissues. Mutat Res Genom (In press).
9. Wang XW and Harris CC: TP53 tumor suppressor gene: clues to molecular carcinogenesis and cancer therapy. Cancer Surv 28: 169-196, 1996.
10. FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH and Haber DA: Germ-line BRCA1 mutations in Jewish and non-Jewish women with early onset breast cancer. N Engl J Med 334: 143-149, 1996.
11. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N and Peretz T: The Founder mutations ISSdelAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60: 505-514, 1997.
12. Middleman MN, Lush RM, Sartor O, Reed E and Figg WD: Androgen-independent prostate cancer and antiandrogen withdrawal: the molecular basis and clinical implications. Cancer Treatment Rev 22: 105-118, 1996.
13. Reed E: The chemotherapy of ovarian cancer. PPO Updates 10: 1-12, 1996.
14. Reed E: Ovarian cancer: molecular abnormalities. In: The Encyclopedia of Cancer. Bertino JR (ed). Academic Press, Inc., San Diego, pp 1192-1200, 1996.
15. Sancar A: Mechanisms of DNA excision repair. Science 266: 1954-1956, 1994.
16. Shivji MKK, Kenny MK and Wood RD: Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69: 367-374, 1992.
17. Mu D, Park C-H, Matsunaga T, Hsu DS, Reardon JT and Sancar A: Reconstitution of human DNA Repair excision nuclease in a highly defined system. J Biol Chem 270: 2415-2418, 1995.
18. Mu D, Hsu DS and Sancar A: Reaction mechanism of human DNA repair excision nuclease. J Biol Chem 271: 8285-8294, 1996.